PRESS RELEASE published on 01/23/2025 at 22:05, 1 year 1 month ago Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress Abivax announces presentation of seven abstracts for Obefazimod in ulcerative colitis at 2025 European Crohn's and Colitis Organization 20th Annual Congress Abivax Obefazimod Ulcerative Colitis Clinical Trials ECCO
PRESS RELEASE published on 01/09/2025 at 17:44, 1 year 2 months ago Abivax franchit une étape clé dans le recrutement de l’essai de phase 3 ABTECT Abivax franchit une étape clé dans le recrutement de l'essai de phase 3 ABTECT pour le traitement de la RCH. Objectif de recrutement proche de 82%. Premiers résultats attendus en 2025 Abivax Recrutement Phase 3 ABTECT RCH
BRIEF published on 01/09/2025 at 17:40, 1 year 2 months ago Abivax Reaches Key Enrollment Milestone in Phase 3 ABTECT Trial Abivax Obefazimod Ulcerative Colitis Phase 3 Trial Clinical Results
BRIEF published on 01/09/2025 at 17:40, 1 year 2 months ago Abivax franchit une étape clé dans le recrutement de l'essai de phase 3 ABTECT Abivax Obefazimod Rectocolite Hémorragique Essai De Phase 3 Résultats Cliniques
PRESS RELEASE published on 01/09/2025 at 17:35, 1 year 2 months ago Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Abivax achieves key milestone in Phase 3 ABTECT trial enrollment with 82% of target participants enrolled for evaluating obefazimod in ulcerative colitis, aiming for NDA submission by H2 2026 Abivax Obefazimod Ulcerative Colitis Phase 3 ABTECT Trial
BRIEF published on 12/23/2024 at 22:10, 1 year 2 months ago Abivax Announces Board Resignation Abivax Obefazimod Board Resignation Truffle Capital Philippe Pouletty
BRIEF published on 12/23/2024 at 22:10, 1 year 2 months ago Abivax annonce la démission de son conseil d'administration Abivax Obefazimod Démission Du Conseil D'administration La Capitale De La Truffe Philippe Pouletty
PRESS RELEASE published on 12/23/2024 at 22:05, 1 year 2 months ago Abivax annonce une modification de la composition de son Conseil d'administration Abivax annonce la démission du Dr Philippe Pouletty en tant qu'administrateur et recherche un nouveau membre du Conseil d'administration. Plus d'informations sur www.abivax.com Abivax Conseil D'administration Rectocolite Hémorragique Démission Maladies Inflammatoires
PRESS RELEASE published on 12/23/2024 at 22:05, 1 year 2 months ago Abivax annonce une modification de la composition de son Conseil d'administration Abivax annonce la démission du Dr. Philippe Pouletty en tant qu'administrateur et recherche un nouveau membre du Conseil d'administration pour soutenir le développement de thérapies. Détails sur www.abivax.com Innovation Abivax Conseil D'administration Démission Thérapies
PRESS RELEASE published on 12/23/2024 at 22:05, 1 year 2 months ago Abivax Announces a Change to the Composition of its Board of Directors Abivax announces a change in its Board of Directors composition as Dr. Philippe Pouletty resigns due to new appointment. The company expresses gratitude for his contributions Board Of Directors Resignation Abivax Therapeutics Dr. Philippe Pouletty
Published on 03/23/2026 at 02:00, 4 hours 43 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 13:30, 2 days 17 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/23/2026 at 03:35, 3 hours 8 minutes ago Deye 2026 Frankfurt Distributor & Partner Summit Concludes Successfully
Published on 03/22/2026 at 12:23, 18 hours 20 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days 7 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 9 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 19:00, 2 days 11 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 11 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 12 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 12 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA